A PHASE I-II STUDY OF BIALKYLATOR CHEMOTHERAPY, HIGH-DOSE THIOTEPA, AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS BONE-MARROW REINFUSION IN PATIENTS WITH ADVANCED CANCER

被引：64
|
作者：
WILLIAMS, SF
BITRAN, JD
KAMINER, L
WESTBROOK, C
JACOBS, R
ASHENHURST, J
ROBIN, E
PURL, S
BESCHORNER, J
SCHROEDER, C
GOLOMB, HM
机构：
[1] UNIV CHICAGO,DEPT MED,JOINT SECT HEMATOL ONCOL,AUTOLOGOUS BONE MARROW TRANSPLANT PROGRAM,CHICAGO,IL 60637
[2] UNIV CHICAGO,MICHAEL REESE HOSP & MED CTR,CHICAGO,IL 60616
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1987年 / 5卷 / 02期
关键词：
D O I：
10.1200/JCO.1987.5.2.260
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：260 / 265
页数：6
相关论文
共 50 条
  • [11] HIGH-DOSE CARBOPLATIN, ETOPOSIDE AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR THE TREATMENT OF ADVANCED MALIGNANCIES - A PHASE-I STUDY
    SAEZ, RA
    SLEASE, RB
    STRNAD, C
    SELBY, GB
    CONFER, DL
    EPSTEIN, RB
    BONE MARROW TRANSPLANTATION, 1995, 16 (04) : 507 - 514
  • [12] PHASE I-II TRIAL OF HIGH-DOSE CYCLOPHOSPHAMIDE, CARBOPLATIN AND AUTOLOGOUS BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL RESCUE
    SPITZER, TR
    CIRENZA, E
    MCAFEE, S
    FOELBER, R
    ZARZIN, J
    CAHILL, R
    MAZUMDER, A
    BONE MARROW TRANSPLANTATION, 1995, 15 (04) : 537 - 542
  • [13] High dose thiotepa and careoplantinum preparative regimen for autologous bone marrow transplantation (BMT): A phase I-II study.
    Schriber, J
    Christiansen, N
    Baer, MR
    Stack, J
    Wetzler, M
    Herzig, G
    BLOOD, 1995, 86 (10) : 3845 - 3845
  • [14] ANALYSIS OF FACTORS INFLUENCING HEMATOLOGIC RECOVERY IN PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW REINFUSION
    KAMINER, L
    WILLIAMS, S
    BITRANI, J
    GOLOMB, H
    WESTBROOK, C
    ROYSTON, K
    CLINICAL RESEARCH, 1986, 34 (04): : A967 - A967
  • [15] PLASMA PHARMACOKINETICS OF HIGH-DOSE ORAL MELPHALAN IN PATIENTS TREATED WITH TRIALKYLATOR CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW REINFUSION
    CHOI, KE
    RATAIN, MJ
    WILLIAMS, SF
    GOLICK, JA
    BESCHORNER, JC
    FULLEM, LJ
    BITRAN, JD
    CANCER RESEARCH, 1989, 49 (05) : 1318 - 1321
  • [16] ANALYSIS OF FACTORS INFLUENCING HEMATOLOGIC RECOVERY IN PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW REINFUSION
    WILLIAMS, SF
    BITRAN, JD
    BARKER, CM
    GRADISHAR, WJ
    KAMINER, LS
    GOLOMB, HM
    ROYSTON, K
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 231 - 231
  • [17] AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND HIGH-DOSE CHEMOTHERAPY
    PHILIP, T
    PLOUVIER, E
    ROZENBAUM, A
    BIRON, P
    VUVAN, H
    EHRSAM, A
    BERGERAT, JP
    BEHART, C
    CORDIER, JF
    FREYCON, F
    HERVE, P
    LYON MEDICAL, 1981, 246 (15): : 137 - 148
  • [18] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    SPITZER, G
    DICKE, K
    ZANDER, AR
    JAGANNATH, S
    VELLEKOOP, L
    FREIREICH, EJ
    CANCER, 1984, 54 (06) : 1216 - 1225
  • [19] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSFUSION
    SPITZER, G
    DICKE, KA
    VERMA, DS
    ZANDER, A
    LITAM, J
    DISTEFANO, A
    LANZOTTI, V
    EXPERIMENTAL HEMATOLOGY, 1979, 7 : 38 - 53
  • [20] HIGH-DOSE, MULTIPLE-ALKYLATOR CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW REINFUSION IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG-CANCER
    WILLIAMS, SF
    BITRAN, JD
    HOFFMAN, PC
    ROBIN, E
    FULLEM, L
    BESCHORNER, J
    GOLICK, J
    GOLOMB, HM
    CANCER, 1989, 63 (02) : 238 - 242
12345